A method for estimating and testing area under the curve in serial sacrifice, batch, and complete data designs
Related Experiment Video
Updated: Oct 19, 2026

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)
Published on: May 10, 2016
1Biometrics Research, Merck Research Laboratories, West Point, Pennsylvania 19486, USA.
Abstract:
The extent of drug availability is often measured by the area under the concentration-time curve. In animal studies, experimental constraints can limit the number of observations available on each animal. Estimation of area under the curve and its standard error are straightforward when each animal is measured at each time point. Bailer and Nedelman et al., have described techniques for estimating the area under the curve and its standard error when each animal is measured once. Yeh has described a technique for the hybrid case where animals are measured more than once, but not at all time points. We describe a method for estimating area under the curve and its standard error which is applicable to all three types of designs. We give formulas for testing treatment differences, including dose trends and dose proportionality, in area under the curve for designs containing an arbitrary number of treatments. A jackknife estimator is also described.
Related Concept Videos
Bioavailability Study Design: Single Versus Multiple Dose Studies
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
On...
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution
Bioequivalence Data: Statistical Interpretation
